In their 2018 study, Xu et al. demonstrated that decreased expression of miRNA-218 correspondingly elevates the expression of GLUT1 in tumor tissues during the advanced stages of tumor development, contributing to the progression of the tumor [21]. The gene discussed is SLC2A1; the disease is neoplasm.